The worldwide market for eubiotics is estimated to grow at a CAGR of 5.6% between 2018 and 2026. Eubiotics have always been a major component for healthy maintenance of equilibrium of micro flora in the gastrointestinal tract. The ban in several countries on several varieties of antibiotics not to be used as growth promoters in animal feed has made eubiotics the paramount alternative. This is expected to be one among the most significant drivers for the growth of eubiotics market from 2018 to 2026.
These products have opened up new horizons for the management of gastro intestinal health without the use of antibiotics. Various types of eubiotics have shown significantly affirmative effect on gut health and animal wellness and healthiness. However, the efficacy of these components is mainly based on antimicrobial effects and their capability to influence and partially transform the composition and general concentration of intestinal microflora. Some of the beneficial effects of eubiotics especially organic acids include improvement of palatability and reduction of diet pH, preservative and antimicrobial effects in feed, enhancement of pepsin activity, reduction of gastric pH, enhanced disability of ingredients, reduction of diarrhea and coliforms, and effects on microflora in the gastro-intestinal tract. These advantages of using adequate amount of eubiotics in feed lead to a balanced nutritional supply for livestock and eventually result in higher productivity of dairy products and enhanced quality of meat.
These are defined as non-antibiotic products that maintain the preferred balance of pathogens or eubiotics and good bacteria in the digestive tract. Eubiotics as a broader term includes four subcategories including the direct acting gut flora, prebiotics, probiotics, immune modulators and essential oils. Since the ban on antibiotics, variety of these products has been introduced in the market with different modes of action yet having an identical functional purpose of maintaining the desired ratio between pathogens and good bacteria.
Eubiotics significantly add to the performance of farm animals without any side effects. Several research projects have shown that dietary addition of 0.5% of benzoic acid resulted in an average improvement of 5.7% to 10.6% feed conversion and in weight gain respectively when compared with a negative control. However, when messed up against different acids (several or blend of acids) and antibacterial agents, it registered an average improvement of 5.7% and 2.1% in weight gain and feed conversion respectively. These advantages of these components over antibiotics are expected to be yet another factor driving demand for eubiotics even in countries where ban on antibiotics is not practiced strictly. The increasing human population globally has resulted in a rising demand for animal protein in diets. The resultant resource pressures have urged for improved production efficiency as consumers demand for more natural production processes. And this production process should include both reduced use of antibiotics and risk of food borne illness/pathogens.
Europe has been the largest consumer of eubiotics globally since its ban on antibiotics use in 2006. The consumers being affluent in the region, animal welfare, safety, quality, sustainability are some of the vital considerations. The retailers have been keeping close tabs on these types of developments as for them; certifications and traceability are some of the crucial factors to stay active in their business. In the North American region, especially in USA the revolution is still less marked compared to in Europe even though organic production have been on the rise due to significant surge in demand for naturally produced products. With all of these in regard a few of the food processing companies started marketing antibiotic free meat and meat products in Europe.
In the Asia Pacific region China and Korea have been significant contributors to the region’s demand for these products. Korea’s Ministry for Food, Agriculture, Forestry, and Fisheries has tightening restrictions on the use of antibiotics in animal feed. The USDA has stated that Korea has almost phased down the number of allowable drugs as an attempt for reducing the country’s overall utilization in compound feed that is premixed during production. These trends in different geographies have created significant opportunities for further penetration of these components. These are expected to amplify even further in the near future driving demand of eubiotics globally.
Some of the leading industry participants include BASF SE, Cargil, Koninklijke DSM N.V., Novozymes, Kemin Industries, Inc., Addcon, Novus International, Inc., Lallemand, Inc., Beneo Group and Chr. Hansen Holding A/S.